Yahoo
NasdaqCM - Nasdaq Real Time Price USD

GlucoTrack, Inc. (GCTK)

0.3474 +0.0058 (+1.70%)
At close: August 21 at 4:00:01 PM EDT
0.3305 -0.0169 (-4.86%)
After hours: August 21 at 7:53:28 PM EDT
Chart Range Bar
Loading chart for GCTK
  • Previous Close 0.3416
  • Open 0.3378
  • Bid 0.0255 x 3000
  • Ask 0.4418 x 200
  • Day's Range 0.3303 - 0.3698
  • 52 Week Range 0.2500 - 14.1400
  • Volume 686,136
  • Avg. Volume 11,412,020
  • Market Cap (intraday) 3.675M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 0.30
  • EPS (TTM) 1.1500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

glucotrack.com

15

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 8/21/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

GCTK
91.02%
S&P 500 (^GSPC)
12.11%

1-Year Return

GCTK
93.63%
S&P 500 (^GSPC)
20.47%

3-Year Return

GCTK
99.98%
S&P 500 (^GSPC)
74.43%

5-Year Return

GCTK
100.00%
S&P 500 (^GSPC)
72.78%

Statistics

View More

Valuation Measures

Annual
As of 5/18/2026
  • Market Cap

    3.61M

  • Enterprise Value

    4.45M

  • Trailing P/E

    0.30

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.65

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -164.45%

  • Return on Equity (ttm)

    -620.63%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -15.95M

  • Diluted EPS (ttm)

    1.1500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.12M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -10.39M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

0.3474 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: